Stockscreener 앱 받기
1.20
0.83%
-0.01
시장 영업 전:
1.21
0.01
+0.83%
Lucid Diagnostics Inc 주식(LUCD)의 최신 뉴스
Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume - ADVFN
PAVmed Provides Business Update and Second Quarter 2024 Financial Results - ADVFN
Lucid Diagnostics finalizes public offering of common stock - Medical Buyer
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock - The Bradford Era
Lucid Diagnostics Closes $16.1 Million Public Offering - MSN
Lucid Diagnostics completes $16.1 million stock offering By Investing.com - Investing.com South Africa
Lucid Diagnostics Raises $16.1 Mln Through Public Offering To Support Corporate Growth - Nasdaq
Lucid Diagnostics stock falls after pricing capital raise of $15M via stock offering - MSN
Lucid Diagnostics Inc (LUCD) With A Potential Upside Of More Than -100.0% - stocksregister.com
Lucid Diagnostics: DNA Testing To Get Medicare Coverage, Driving Volumes, Says Bullish Analyst - Benzinga
Lucid Diagnostics Announces Closing of Public Offering of Common Stock - GuruFocus
Lucid Diagnostics completes $16.1 million stock offering - Investing.com Australia
Lucid Diagnostics Announces Closing Of Public Offering Of Common Stock - marketscreener.com
Lucid Diagnostics Raises $16.1M: Cancer Detection Company Strengthens Financial Position - Stock Titan
Indo-Asian News Service - Indo-Asian News Service (IANS)
Lucid Diagnostics Shares Fall After Pricing Stock Offering - marketscreener.com
Lucid Diagnostics Announces Public Stock Offering - TipRanks
Lucid Diagnostics Stock Sinks After-Hours On Equity Raise, But Retail Dives In Anyway - MSN
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock (PR Newswire) - Aktiellt
Lucid Diagnostics Announces Proposed Public Offering of Common Stock - The Malaysian Reserve
Lucid Diagnostics announces proposed public offering of common stock - MSN
Lucid Diagnostics Announces Pricing Of Public Offering Of Common Stock - MarketScreener
Medical Diagnostics Pioneer Lucid Secures $15M Strategic Financing Round - Stock Titan
Lucid Diagnostics plans stock offering to boost capital By Investing.com - Investing.com South Africa
Lucid Diagnostics Announces Proposed Public Offering of Common S - GuruFocus
SEC Form 424B5 filed by Lucid Diagnostics Inc. - Quantisnow
Lucid Diagnostics plans stock offering to boost capital - Investing.com Australia
Lucid Diagnostics Announces Proposed Public Offering Of Common Stock - MarketScreener
Commercial-Stage Cancer Prevention Company Lucid Diagnostics Unveils Strategic Funding Move - Stock Titan
Indo-Asian News Service-LUCID DIAGNOSTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK - Indo-Asian News Service (IANS)
Indo-Asian News Service-LUCID DIAGNOSTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK - Indo-Asian News Service (IANS)
Lucid Diagnostics stock soars to 52-week high of $1.64 - Investing.com Australia
Lucid Diagnostics stock soars to 52-week high of $1.64 By Investing.com - Investing.com South Africa
Pavmed Inc Files For Offering Of 3.3 Million Shares Of Common Stock - marketscreener.com
Lucid Diagnostics to Participate in Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference - BioSpace
Lucid Diagnostics to Participate in Fireside Chat at the 24th An - GuruFocus
PAVmed outlines strategic milestones for 2025, including Veris implantable device submission - MSN
Pavmed’s Strategic Growth and Financial Challenges - MSN
[New] Lucid Stock Price Prediction 2024, 2025 To 2050 - Exla Resources
Lucid Diagnostics (NASDAQ:LUCD) Stock Price Expected to Rise, Needham & Company LLC Analyst Says - MarketBeat
Game-Changing Cancer Detection: EsoCheck Achieves 99% Accuracy Across 30,000 Patient Study - Stock Titan
Cantor Fitzgerald maintains Lucid Diagnostics stock at overweight By Investing.com - Investing.com Canada
Analysts Are Bullish on Top Healthcare Stocks: Quince Therapeutics (QNCX), Lucid Diagnostics (LUCD) - The Globe and Mail
Cantor Fitzgerald maintains Lucid Diagnostics stock at overweight - Investing.com India
1.79%
자본화:
|
볼륨(24시간):